Results 161 to 170 of about 333,286,368 (302)

Switching Ionization Polarity to Simplify MS/MS Sequencing of Digital Polymers: the Case of Informational Poly(Amino phosphodiester)s. [PDF]

Rapid Commun Mass Spectrom
Sergent I, Roszak I, Lutz JF, Charles L.
europepmc   +1 more source

Food labelling [PDF]

British Dental Journal, 2005
S, Creanor, D, Conway
openaire   +2 more sources

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Minimally Destructive Radiocarbon Dating of Bone. [PDF]

Rapid Commun Mass Spectrom
Higham T, Luftensteiner K, van der Sluis L, Giannì M, Wiegele M, Papadogianni A, Steier P, Gruber D, Schmidt B, Schmidt K, Belinski A, Mensan R, Kozlikin M, Shunkov M, Neruda P, Nerudová Z, Horejs B, Schulze J, Douka K, Stafford TW.   +19 more
europepmc   +1 more source

In Silico Labeling: Predicting Fluorescent Labels in Unlabeled Images

Cell, 2018
Eric M. Christiansen, Samuel J. Yang, D. Ando, A. Javaherian, G. Skibinski, S. Lipnick, Elliot Mount, Alison O’Neil, K. Shah, Alicia K. Lee, P. Goyal, W. Fedus, R. Poplin, A. Esteva, Marc Berndl, Lee L. Rubin, Philip Nelson, S. Finkbeiner   +17 more
semanticscholar   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

Molecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande, Marcela de Oliveira Silva, Mariana Bisarro dos Reis, Rodrigo de Oliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira da Silva, Pedro de Marchi, Letícia Ferro Leal, Rui M. Reis   +11 more
wiley   +1 more source

Origins of Face Responses in the Human Cortex: fNIRS and fMRI Evidence From Infants. [PDF]

Curr Dir Psychol Sci
Saxe R, Kosakowski HL.
europepmc   +1 more source

HaloTag: a novel protein labeling technology for cell imaging and protein analysis.

ACS Chemical Biology, 2008
G. Los, L. Encell, M. Mcdougall, Danette D Hartzell, N. Karassina, Chad A. Zimprich, Monika G Wood, R. Learish, R. Ohana, M. Urh, D. Simpson, Jacqui Méndez, Kris Zimmerman, Paul E. Otto, G. Vidugiris, Ji Zhu, A. Darzins, D. Klaubert, R. F. Bulleit, K. Wood   +19 more
semanticscholar   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Agreeing to disagree: When do superordinate identities facilitate competing opinion-based groups to work through intergroup conflict? [PDF]

Br J Soc Psychol
Haines EA, Thomas EF, Wenzel M.
europepmc   +1 more source